Ciprofloxacin-associated Clostridium difficile disease. 1995

L V McFarland, and J E Bauwens, and S A Melcher, and C M Surawicz, and R N Greenberg, and G W Elmer

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002939 Ciprofloxacin A broad-spectrum antimicrobial carboxyfluoroquinoline. Bay-09867,Ciprinol,Cipro,Ciprofloxacin Hydrochloride,Ciprofloxacin Hydrochloride Anhydrous,Ciprofloxacin Monohydrochloride Monohydrate,Anhydrous, Ciprofloxacin Hydrochloride,Bay 09867,Bay09867,Hydrochloride Anhydrous, Ciprofloxacin,Hydrochloride, Ciprofloxacin,Monohydrate, Ciprofloxacin Monohydrochloride,Monohydrochloride Monohydrate, Ciprofloxacin
D004761 Enterocolitis, Pseudomembranous An acute inflammation of the INTESTINAL MUCOSA that is characterized by the presence of pseudomembranes or plaques in the SMALL INTESTINE (pseudomembranous enteritis) and the LARGE INTESTINE (pseudomembranous colitis). It is commonly associated with antibiotic therapy and CLOSTRIDIUM DIFFICILE colonization. Antibiotic-Associated Colitis,Clostridium Enterocolitis,Colitis, Pseudomembranous,Enteritis, Pseudomembranous,Pseudomembranous Colitis,Pseudomembranous Enteritis,Pseudomembranous Enterocolitis,Antibiotic Associated Colitis,Colitis, Antibiotic-Associated
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D016360 Clostridioides difficile A common inhabitant of the colon flora in human infants and sometimes in adults. The type species Clostridioides difficile is formerly known as Clostridium difficile. It is a causative agent for CLOSTRIDIOIDES INFECTIONS and is associated with PSEUDOMEMBRANOUS ENTEROCOLITIS in patients receiving antibiotic therapy. Clostridium difficile

Related Publications

L V McFarland, and J E Bauwens, and S A Melcher, and C M Surawicz, and R N Greenberg, and G W Elmer
November 2002, Infection control and hospital epidemiology,
L V McFarland, and J E Bauwens, and S A Melcher, and C M Surawicz, and R N Greenberg, and G W Elmer
August 1992, The Journal of antimicrobial chemotherapy,
L V McFarland, and J E Bauwens, and S A Melcher, and C M Surawicz, and R N Greenberg, and G W Elmer
May 1991, The Journal of infection,
L V McFarland, and J E Bauwens, and S A Melcher, and C M Surawicz, and R N Greenberg, and G W Elmer
December 1996, Anales de medicina interna (Madrid, Spain : 1984),
L V McFarland, and J E Bauwens, and S A Melcher, and C M Surawicz, and R N Greenberg, and G W Elmer
December 2006, South Dakota medicine : the journal of the South Dakota State Medical Association,
L V McFarland, and J E Bauwens, and S A Melcher, and C M Surawicz, and R N Greenberg, and G W Elmer
January 2005, Journal of veterinary internal medicine,
L V McFarland, and J E Bauwens, and S A Melcher, and C M Surawicz, and R N Greenberg, and G W Elmer
October 2018, BMJ (Clinical research ed.),
L V McFarland, and J E Bauwens, and S A Melcher, and C M Surawicz, and R N Greenberg, and G W Elmer
November 1990, Lancet (London, England),
L V McFarland, and J E Bauwens, and S A Melcher, and C M Surawicz, and R N Greenberg, and G W Elmer
December 2002, Current infectious disease reports,
L V McFarland, and J E Bauwens, and S A Melcher, and C M Surawicz, and R N Greenberg, and G W Elmer
January 2007, Current opinion in gastroenterology,
Copied contents to your clipboard!